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Mitral regurgitation may be treated either by valve
repair or valve replacement. Historically, repair
with or without prosthetic material was the first
method used to restore mitral valve competence. In
1957 Lillehei and co-workers'1' reported on the
successful correction of mitral insufficiency by
annuloplasty. These early reparative techniques
were shown to be quite effective because normaliz-
ation of huge left atrial v-wave was documented
after repaid2!. In 1961 Starr and Edwards'31
reported on the first clinically successful implan-
tation of a ball valve prosthesis in the mitral
position. Thereafter, cardiac surgeons in the
United States preferred the certainty of haemo-
dynamic correction by valve replacement to the
possibility of late progression of disease with the
reparative procedures. In contrast, European car-
diac surgeons under the leadership of Carpentier
in France!4-5), Duran in Spain'6' and Yacoub in
England!'! continued to use valve repair with
steadily improving technique. In recent years, there
has been renewed interest in repair in the United
States. At the Cleveland Clinic, for instance, the
percentage of mitral valve repairs increased from
5% in 1980 to about 30% of all mitral valve
procedures in 1984!8).
This brief overview of the pros and cons of
mitral valve repair versus valve replacement in
patients with chronic mitral regurgitation is based
predominantly on reports which contain data
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obtained with both surgical procedures from the
same institution. It should, however, be empha-
sized that even within this selected material there
may be some differences in the patient populations
treated with the two surgical methods, that the
time periods during which the surgical interven-
tions were carried out may not always be strictly
the same and the time of follow-up may then vafy
as well. Moreover there are various types of repara-
tive procedures (annuloplasty with or without ring,
valvuloplasty, chordal imbrication, closure of per-
foration etc.) which are used according to the under-
lying pathology of the incompetent mitral valve'4-51
and which may give different results in different
hands. It is, however, beyond the scope of this
short review to analyse in detail the outcome of
surgery according to the specific type and extent of
mitral valve repair.
Early operative mortality (Table 1)
When 8 recent studies were averaged, early
mortality was 3 1 % with repair and 7% with
mitral valve replacement. The higher mortality
with mitral valve replacement was particularly
striking in the studies of Duran et a/.'6' and of
Perier et alP\ whereas Oliveira et a/.'10! reported
almost the same mortality with both surgical tech-
niques. In the series of the University Hospital in
Zurich'"! of patients operated between 1972 and
1982, operative mortality was somewhat higher with
repair than with mitral valve replacement although
the difference was not statistically significant. As far
as preoperative symptomatic status (NYHA class)
and age are concerned, five studies16-7-9-10-12' reported
similar data in the groups with mitral valve replace-
ment and repair (Table 1). In two studies'1113',
patients undergoing repair were younger than
those who had mitral valve replacement; operative
mortality, however did not differ.
0195-668X 86 080638 + 06 S02.00 0 1986 The European Society of Cardiology
Surgery for mitral regurgitation 639
V"
Tablet Early (operative) mortality in mitral regurgitation
Author
Duran (6)
Yacoub(7)
Oliveira (10)
Pener (9)
Adebo(12)
Orszulak(13)
Cosgrove (8)
Schmidli (11)
Mean
Year
1980
1981
1983
1984
1984
1985
1985
1985
Mortality
114
70
50
120 (BP)
130 (SE)
120 (BS)
6-8
7-5
4 6
1-6
70
MVR
NYHA
31
87%
III/IV
56%
III/IV
2-5
2-5
2-4
73%
III/IV
2-8
A
43-3
55-3
56
49-6
51-8
51-4
62
64
55-5
Mortality
1-8
31
4-9
2 0
0
61
2-3
4-8
31
Repair
NYHA
mean 2-7
83%
III/IV
51%
III/IV
mean 2-4
81%
III/IV
79%
III/IV
mean 2-8
A
41-4
53-8
59
47-1
62
57
42-4
BP = bioprosthesis, BS = Bjork-Shiley prosthesis, MVR = mitral valve replacement, SE = Starr-Edwards prosthesis,
NYHA = functional class according to the New York Heart Association, A = mean age in years.
Survival after surgery (Table 2)
In all 7 studies from which survival data follow-
ing both mitral valve replacement and repair were
available, 5-year survival was clearly better after
repair than after mitral valve replacement (89
versus 74%). The higher survival with repair is not
only due to a lower operative mortality with this
procedure, because in the two studies of Oliveira et
a/.i'oj and Schmidli et a/.l") which showed no differ-
ence in early mortality, 5-year survival with repair
exceeded that after valve replacement. This better
survival after repair irrespective of early mortality
is essentially related to less thromboembolism and
better postoperative left ventricular function with
repair than with mitral valve replacement.
Thromboembolism after surgery (Table 3)
The rate of thromboembolism averaged 0-9%
per year with repair and 4-1 % per year with mitral
valve replacement. The difference in the rate of
thromboembolism was especially marked when
repair was compared with valve replacement with
Starr-Edwards or Bjork-Shiley prosthesesi". When
bioprostheses were used for mitral valve replace-
ment as in the studies of Duran et all® and Perier et
Table 2 5-year survival after surgery for mitral regurgitation
Author
Duran (6)
Yacoub (7)
Oliveira (10)
Perier (9)
Adebo(12)
Orszulak(13)
Schmidli (11)
Mean
Year
1980
1981
1983
1984
1984
1985
1985
MVR
(4-5 yrs) 81
62
75
70
67
65
78
72
80
74
(BP)
(SE)
(BS)
Repair
96
90
88
86
85
88
87
89
BP = bioprosthesis, BS = Bjork-Shiley prosthesis, MVR
mitral valve replacement, SE = Starr-Edwards prosthesis.
, the difference in thromboembolism with
respect to repair was less evident.
Inspection of Table 3 reveals that especially after
mitral valve replacement there were large differ-
ences in the rate of thromboembolism between the
various studies. Undoubtedly, they are related to
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the definition of thromboembolism used by the dif-
ferent authors. For instance, in one studyi'°] a
thromboembolism was defined as a sudden new
postoperative neurological disturbance resulting in
a permanent deficit, whereas Duran et a/.'6' counted
as thromboembolism any suspicious postoperative
event reported by the patient, relatives or family
physician. These interauthor differences in defi-
nition of thromboembolism should, however, not
invalidate the comparison of the rate of thrombo-
embolism after repair and mitral valve replacement
from the data given in Table 3 because only paired
observations of the various centres were included.
Haemorrhagic complications after repair are few
because only a minority of patients are maintained
Table 3 Thromboembolism after surgery for mitral
regurgitation
Author
Duran (6)
Oliveira(lO)
Perier (9)
Adebo(12)
Orszulak(13)
Schmidli(ll)
Mean
Year
1980
1983
1984
1984
1985
1985
(%
4-1
1-4
1-9
50
5-8
4-8
8 0
21
41
MVR
per year)
(BP)
(SE)
(BS)
Repair
(% per year)
2-4
0-2
0-3
0
1-8
0-7
0-9
BP = bioprosthesis, BS = Bjork-Shiley prosthesis, MVR =
mitral valve replacement, SE = Starr-Edwards prosthesis.
on long-term anticoagulation. Persistent atrial
fibrillation is considered an indication for long-
term anticoagulation by some authors!'4' whereas
others!7' discontinue oral anticoagulants in all
patients 6 weeks after surgery.
Postoperative left ventricular function (Table 4)
Echocardiography"5', radionuclide tech-
niques[1<M8' and cineventriculographyi6'14"-21' have
been used to determine left ventricular ejection
fraction before and after surgery. Early postopera-
tive measurements within one month after surgery
were performed by Boucher et a/.'18', David et a/.[20'
and Bonchek et a/.'21'. The other studies in Table 4
were performed between 3 and 30 months after
surgery. When these admittedly heterogeneous
data were pooled (Table 4) no change in ejection
fraction was observed after repair, whereas after
mitral valve replacement there was a decrease in all
studies except that of Peter et a/.'17'. In our own
material (Figure 1) echocardiographically deter-
mined left ventricular transverse diameter short-
ening decreased significantly after mitral valve
replacement but remained essentially unchanged
following valve reconstruction. Of particular inter-
est is the study of David et a/.'20' because, in
addition to a group with conventional valve
replacement and a group with valvuloplasty, a
third group of patients was reported, who under-
went mitral valve replacement whereby the anterior
leaflet was partially excised but its chordae and the
entire posterior leaflet and its chordae were left
attached to the papillary muscles. In this particu-
lar group with mitral valve replacement ejection
Table 4 LV ejection fraction before and after surgery for mitral regurgitation
Author
Schuler(15)
Duran (6)
Lessana (14)
Phillips (16)
Peter (17)
Boucher (18)
Huikuri(19)
David (20)
Bonchek (21)
Mean
Year
1979
1980
1981
1981
1981
1981
1983
1983
1984
Method
Echo
Angio
Angio
Radionuclide
Radionuclide
Radionuclide
Angio
Angio
Angio
pre
66
54
62
56
66
58
62
61
MVR
post
47
47
50
54
48
50
51
- . 50
pre
70
47
58
63
66
61
Repair
post
65
54
52
68
62
- 60
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Figure 1 Echocardiographic assessment of left heart size and function before and
after surgery for chronic mitral regurgitation. Prior to surgery left atrial (LAD)
and left ventricular end-diastolic (LVEDD) diameter was increased to a similar
extent in both-the group with mitral valve replacement and mitral valve recon-
struction. Similarly there was no difference in left ventricular transverse diameter
systolic shortening (LV Sh,%) before surgery. Postoperatively, LVEDD and
LAD decreased in both groups. Left ventricular transverse diameter shortening
remained within the normal range after reconstruction whereas after valve
replacement it decreased significantly. Hence, left ventricular ejection performance
is preserved after repair but not after valve replacement. (Courtesy by Prof. M.
Rothlin, Clinic for Cardiovascular Surgery, University Hospital, Zurich).
Table 5 LV end-diastolic volume index before and after surgery for mitral regurgitation
Author
Lessana(14)
Boucher (18)
Huikuri(19)
David (20)
Bonchek(21)
Mean
Year
1981
1981
1983
1983
1984
Method
Angio
Radionuclide
Angio
Angio
Angio
pre
(ml/m
131
138
108
126
MVR
post
2) (ml/m2)
78
100
101
- 93
pre
(ml/m
148
123
143
138
Repair
post
2) (ml/m2)
89
96
84
- 90
fraction remained unchanged after surgery in con-
trast to the group with conventional mitral valve
replacement in which ejection fraction decreased.
In the group with valvuloplasty, ejection fraction
did not change. Hence, it is evident that the con-
tinuity between mitral annulus and left ventricular
wall through the leaflets, chordae tendineae and
papillary muscles plays a major role in the preser-
vation of left ventricular function after correction
of chronic mitral regurgitation. The less favourable
postoperative left ventricular function after con-
ventional mitral valve replacement appears to be
due to a loss of long-axis shortening and distention
or disruption of the basilar musculature.
With respect to the postoperative changes of left
ventricular end-diastolic volume index (Table 5),
the pooled data do not show a major difference
between repair and mitral valve replacement. With
both surgical methods end-diastolic volume index
decreased although in the study of David et a/.'20'
the decrease was significant only after repair but
not after mitral valve replacement.
Left ventricular filling dynamics as assessed by
the echocardiographic peak velocity of transverse
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diameter lengthening was found by St John Sutton
et a/.'22) to be close to normal after valve repair
whereas this quantity was depressed following
mitral valve replacement by mechanical as well as
by Hancock prostheses.
Reoperations after surgery for mitral regurgitation
(Table 6)
To make the analysis as complete as possible,
some recent studies were included from institutions
in which reoperations solely after repair!10'13'23'24) or
after mitral valve replacement'25) were reported.
When all these data are pooled it is apparent that
reoperations after repair (2-2% per year) are twice
as frequent as they are after mitral valve replace-
ment ( 1 1 % per year). It should, however, be noted
that the excellent study of Perier et al.w which
included 3 groups with mitral valve replacement
and one group with repair, followed during the-
same time-period at the same institution, showed
no significant difference in the rate of reoperation
after repair and mitral valve replacement.
The incidence of infective endocarditis appears to
be less after repair than after mitral valve replace-
ment. In Duran's161 series, infective endocarditis
occurred at a rate of 0-4% per year after repair and
of 2-2% per year after mitral valve replacement.
Follow-up observations from our hospital'"'
Table 6 Reoperalions after surgery for mitral regurgitation
Author Year MVR(% per year)
Repair
(% per year)
Duran(6) 1980 0-9 (BP) 1-6
Yacoub(7) 1981 1-3 (Homogr.) 0-9
Oliveira(lO) 1983 — 1-7
Perier (9) 1984 2-4 (BP) 1-6
0-9 (SE)
2-3 (BS)
Adebo(12) 1984 0 (59% BP 1-2
41% MP)
Nunley(23) 1984 — 4-5
Orszulak(13) 1985 — 2-8
Schmidli(ll) 1985 15 (47% BP 2-3
53% MP)
Penkoske(24) 1985 — 3-5
Mitchell (25) 1985 0-8 (SE) —
10 (BP)
Mean 11 (6 studies) 2-2 (9 studies)
Legends: Homogr = fresh aortic homograft, MP = mechani-
cal prosthesis, other abbreviations as in Table 1.
revealed no infective endocarditis in 42 patients
with mitral valve reconstruction whereas it '
occurred in 3 out of 122 patients after mitral valve
replacement (0-8% per year). Similar results have
been reported by othersi7'101.
In summarizing the pros and cons of the use of
repair or valve replacement in the surgical treat-
ment of mitral regurgitation the following points
merit emphasis:
(1) Operative mortality with repair is about half ->
that with valve replacement.
(2) Long-term survival with repair is superior to
that after valve replacement.
(3) Thromboembolism is about 4 times less fre-
quent after repair than after valve replacement.
The most striking differences have been reported
when mechanical valves were compared with repair. '
(4) Postoperative left ventricular systolic and filling
dynamics are preserved following repair, but are
reduced after conventional valve replacement.
(5) Reoperations after repair are on the average
twice as frequent as after mitral valve replacement,
although this trend was not evident in all studies.
(6) Postoperative infective endocarditis seems to
be less frequent after repair than after valve
replacement.
Indications and contraindications for mitral valve
repair
From all the foregoing it would appear that
repair is superior to mitral valve replacement. The
ideal case for repair is a young patient with severe
mitral regurgitation the aetiology being rheumatic
or myxomatous degeneration. Chronic atrial fibril-
lation should not be present, left ventricular sys-
tolic ejection fraction should be within the normal
range and short-term follow-up should show a ..
progression of heart size. At surgical inspection,
valve tissue should be preserved.
Not all types of mitral regurgitation are, how-
ever, amenable to reconstruction. Extensive leaflet
destruction from rheumatic fever or infective endo- ,
carditis cannot be repaired. Other heretofore estab-
lished contraindications such as marked alterations *
of the subvalvular apparatus and multiple rupture
of chordae to the anterior mitral leaflet are becom-
ing more and more relative. In a recent study!261, it
was estimated that reparative techniques can be
effectively used in more than 90% of patients oper-
ated upon with mitral regurgitation. Conservative
 %
mitral surgery may even be performed in an emerg-
ency situation such as in acute ischaemic mitral
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regurgitation. Valve replacement in mitral regurgi-
tation due to coronary artery disease carries a
grave prognosis, the perioperative mortality rang-
ing between 18 and 20%P7-28'. With valve repair
such high risk patients appear to fare considerably
better, Kay et al.w having reported a hospital
mortality as low as 6%. Finally a rare but very
good indication for valve repair is mitral valve
perforation due to aortic valve endocarditis.
In conclusion, valve repair for mitral regurgi-
tation is becoming increasingly popular. It should,
however, be emphasized that because valve repair
operations are inherently not stereotyped and are
often of an improvisational nature, the artistic skill
of the individual cardiac surgeon is and will remain
the key factor for the ultimate result of repair.
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